7 Results for "

vasodilating action

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "vasodilating action" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-100957
CAS No.: 20153-98-4
Purity:  99.64%
Research Areas:  

Cardiovascular Disease

Dilazep dihydrochloride is an inhibitor of adenosine uptake. Dilazep dihydrochloride has cerebral and coronary vasodilating action through enhancement of effect of adenosine. Dilazep dihydrochloride also inhibits the ischemic damage, platelet aggregation, and membrane transport of nucleosides .
loading...
    loading...
Cat. No.: HY-P1556
CAS No.: 141676-35-9
Target:  

PKG

Research Areas:  

Cardiovascular Disease

Vasonatrin Peptide (VNP) is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). Vasonatrin peptide possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP. Vasonatrin Peptide protects the diabetic heart against ischemia-reperfusion injury by inhibiting ER stress via the cGMP-PKG signaling pathway .
loading...
    loading...
Cat. No.: HY-100957R
CAS No.: 20153-98-4
Dilazep (dihydrochloride) (Standard) is the analytical standard of Dilazep (dihydrochloride). This product is intended for research and analytical applications. Dilazep dihydrochloride is an inhibitor of adenosine uptake. Dilazep dihydrochloride has cerebral and coronary vasodilating action through enhancement of effect of adenosine. Dilazep dihydrochloride also inhibits the ischemic damage, platelet aggregation, and membrane transport of nucleosides .
loading...
    loading...
Cat. No.: HY-129445
CAS No.: 83440-03-3
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

SG-209 is a Nicorandil (HY-B0341) derivative that produces relaxation through potassium channel activation, while this action contributes to the vasodilating action of Nicorandil (HY-B0341) at higher concentrations. SG-209 dilates tracheal smooth muscle and increases tracheal blood flow in anesthetized dogs .
loading...
    loading...
Cat. No.: HY-114846
CAS No.: 106134-33-2
Research Areas:  

Cardiovascular Disease

Ro 22-9194 inhibits aggregation and thromboxane Az (TXA2) synthetase activity in rabbit and human platelets. Ro 22-9194 has a potent inhibitory action against various types of model arrhythmias. Ro 22-9194 has non-cholinergic cardiac depressant properties with its vasodilating action .
loading...
    loading...
Cat. No.: HY-P1556A
Target:  

PKG

Research Areas:  

Metabolic Disease

Vasonatrin Peptide (VNP) TFA is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). Vasonatrin peptide TFA possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP. Vasonatrin Peptide TFA protects the diabetic heart against ischemia-reperfusion injury by inhibiting ER stress via the cGMP-PKG signaling pathway .
loading...
    loading...
Cat. No.: HY-100957A
CAS No.: 35898-87-4
Research Areas:  

Cardiovascular Disease

Dilazep is an inhibitor of adenosine uptake. Dilazep has cerebral and coronary vasodilating action through enhancement of effect of adenosine. Dilazep also inhibits the ischemic damage, platelet aggregation, and membrane transport of nucleosides .
loading...
    loading...